Agios Pharma (AGIO) Reports Q2 Loss of $1.47/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. TSLA
6. ISRG
7. SMCI
8. RTX
9. GOOGL
10. S

Go back to Agios Pharma (AGIO) Reports Q2 Loss of $1.47/Share

Agios Reports Second Quarter 2016 Financial Results

August 4, 2016 7:01 AM EDT

- Data from PKR Activators at EHA Demonstrated Proof-of-Concept for AG-348 and Proof-of-Mechanism for AG-519; Program Moving Toward Pivotal Development in PK Deficiency with Molecule Selection by Year-End 2016 -

- $200 Million Upfront Payment Received for New Metabolic Immuno-Oncology Collaboration with Celgene -

CAMBRIDGE, Mass., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the fields of cancer metabolism and rare genetic metabolic disorders, today reported business highlights and financial results for the second quarter ended June 30, 2016.

"Second quarter achievements marked tremendous progress... More